Skip to content

Comparison of the LMA Protector and the I-gel

Comparison of the LMA Protector and the I-gel in Anesthetized Patients.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03078517
Enrollment
110
Registered
2017-03-13
Start date
2017-05-01
Completion date
2018-01-20
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation

Keywords

I-gel, Laryngeal mask airway protector

Brief summary

Investigators aim to compare two supraglottic airway devices; the i-gel and the newly developed laryngeal mask airway protector in terms of airway sealing effect, the insertion success rate, and the incidence of complications in anesthetized patients.

Interventions

DEVICEI-gel

After the induction of anesthesia, i-gel is inserted along the palatopharyngeal curve.

DEVICELaryngeal mask airway protector

After the inudction of anesthesia, laryngeal mask airway protector is inserted along the palatopharyngeal curve, and the cuff is inflated.

Sponsors

SMG-SNU Boramae Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Requirement for mechanical ventilation under general anesthesia

Exclusion criteria

* Surgical position other than supine position * Tumors or anatomical abnormalities in the upper airway * Known or predicted difficult airway * Body mass index \> 30 kg/m2 * Required postoperative mechanical ventilation * Head and neck surgery * Aspiration tendency

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal airway leak pressureAt 5 min after the insertion of i-gel or LMA protectorOropharyngeal airway leak pressure is measured by closing the expiratory valve of the circle system at a fresh gas flow of 3 L/min and observing the airway pressure at equilibrium.

Secondary

MeasureTime frameDescription
Insertion timeDuring the insertion of i-gel or LMA protectorInsertion time is defined as the time from picking up the device to confirming successful placement (the appearance of the ETCO2 on the monitor screen).
Ease of insertionDuring the insertion of i-gel or LMA protectorEase of insertion is defined as follows. Easy: requiring no additional maneuver, fair: requiring 1 additional maneuver, difficult: requiring more than 1 additional maneuver.
Ease of gastric tube insertionAt 25 min after the insertion of i-gel or LMA protectorEase of garstic tube insertion is assessed as follows; easy, difficult, impossible.
Number of insertion attempt for the successful placementDuring the insertion of i-gel or LMA protectorThe numbers of insertion attempt for successful placement are counted.
Blood staining on the i-gel or LMA protectorImmediately after removal of i-gel or LMA protectorAfter removal of the device, the presence of blood staining on the device is checked.
The incidence and severity of postoperative sore throatAt 1 and 24 h after surgeryPostoperative sore throat is assessed using a numerical rating scale (0-100 point).
The accuracy of insertion location of the device in the oropharyngeal spaceAt 15 min after the insertion of i-gel or LMA protectorAfter insertion of the device, the insertion location is assessed using a fiberoptic bronchoscope; 4, only the vocal cords seen; 3, vocal cords and posterior part of the epiglottis seen; 2, vocal cords and anterior part of the epiglottis seen; 1, vocal cords not seen, but adequate ventilation.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026